NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Subcutaneous Calcitonin in Acute Herpes Zoster
Subcutaneous Calcitonin in Acute Herpes Zoster

NCT07655804

RecruitingPhase 3

Sponsor: Tanta University

Conditions: Calcitonin, Subcutaneous, Acute Herpes Zoster

Interventions: Calcitonin, Saline

Countries: Egypt

This prospective randomized controlled study will be conducted to evaluate the effect of adding calcitonin to the standard treatment protocol in patients with acute herpes zoster infection.

Eligibility overview

Sex: ALL

Age: 50 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* patients aged ≥ 50 years, with acute herpes zoster infection (rash duration \< 7 days) and moderate to severe pain.

Exclusion Criteria:

* Coagulation abnormalities
* Pre-existing other pain syndrome or psychological disorders.
* Severe hepatic, cardiovascular, or renal disorders.
* Allergy to calcitonin.
Locations (1)
  • Tanta, Gharbia Governorate, Egypt